Grimes & Company’s St Jude Medical STJ Stock Holding History

Grimes & Company’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-6,425	Closed	-$420K	–	166
2014 Q1	$420K	Sell	6,425 -235	-4%	-$15.3K	0.12%	97
2013 Q4	$413K	Sell	6,660 -41,229	-86%	-$2.39M	0.12%	95
2013 Q3	$2.57M	Sell	47,889 -23,458	-33%	-$1.21M	0.87%	48
2013 Q2	$3.26M	Buy	+71,347	New	+$3.09M	1.19%	40

Other funds holding STJ

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

IIS

Ignis Investment Services Edinburgh, United Kingdom $29.9B AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Grimes & Company's STJ Position: Q2 2014 in Review

Grimes & Company sold out of St Jude Medical (STJ) in Q2 2014, closing a stake of 6,425 shares — an estimated $420K sold.

Grimes & Company first reported a position in STJ in Q2 2013 and held it in 4 quarters. The position peaked at $3.26M in Q2 2013. 555 funds tracked by Wall St. Rank hold STJ as of Q2 2014.

Grimes & Company reported no remaining St Jude Medical position as of Q2 2014 after selling out during the quarter.
Grimes & Company sold 6,425 St Jude Medical shares in Q2 2014, an estimated $420K.
Grimes & Company first reported a position in St Jude Medical in Q2 2013 and held it in 4 quarters.
Grimes & Company's St Jude Medical position peaked at $3.26M in Q2 2013.
555 funds tracked by Wall St. Rank held St Jude Medical as of Q2 2014.

Based on Grimes & Company's 13F filing for Q2 2014, filed 28 Jul 2014.